Clara I. Leandro
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Randomized double-blind study on safety and tolerability of TP-102 phage cocktail in patients with infected and non-infected diabetic foot ulcers.
Journal: Med (New York, N.Y.)
Published: March 25, 2024
EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis.
Journal: Applied microbiology and biotechnology
Published: January 01, 2015
A two-component, multimeric endolysin encoded by a single gene.
Journal: Molecular microbiology
Published: November 06, 2014
In vitro design of a novel lytic bacteriophage cocktail with therapeutic potential against organisms causing diabetic foot infections.
Journal: Journal of medical microbiology
Published: May 30, 2014
Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds.
Journal: Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
Published: August 21, 2012
Phage endolysins with broad antimicrobial activity against Enterococcus faecalis clinical strains.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: April 07, 2012
Novel chimerical endolysins with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: March 22, 2012
A rat model of diabetic wound infection for the evaluation of topical antimicrobial therapies.
Journal: Comparative medicine
Published: February 15, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026